Skip to main content
. 2020 Oct 21;26(39):6087–6097. doi: 10.3748/wjg.v26.i39.6087

Table 1.

Demographic data and clinical parameters

Variable
Value
Age (yr) 70 (60-79)
Sex (male: female) 59:24
Days from onset to admission 10 (7-15)
BMI (kg/m2) 23.8 (22.1-25.1)
APACHEII scores 14.0 (12.0-17.0)
SOFA scores 6.0 (4.0-7.0)
Initial symptoms or signs, n (%)
Fever 33 (39.8)
Cough 18 (21.7)
Chest tightness or pain 8 (9.6)
Dyspnea 7 (8.4)
Fatigue 6 (7.2)
Diarrhea 3 (3.6)
Nausea or vomiting 3 (3.6)
Pharyngalgia/myalgia 3 (3.6)
Abdominal pain 2 (2.4)
Laboratory parameters
CRP (mg/L) 85.9 (49.9-136.0)
WBC (109/L) 10.30 (7.44-14.0)
Lymphocyte (109/L) 0.60 (0.43-0.83)
PCT (ng/mL) 0.27 (0.14-0.50)
D-dimer (μg/mL) 8.29 (2.00-14.19)
Lactate (mmol/L) 2.22 (1.68-2.73)
Organ injury, n (%)
ARDS 77 (92.8)
Liver injury 15 (18.1)
AKI 30 (36.1)
Cardiac injury 37 (44.6)
MODS, n (%) 58 (69.9)
Septic shock, n (%) 16 (19.3)
Duration of MV (d) 9.0 (6.0-13.0)
Duration of CRRT (d) 0.0 (0.0-5.0)
Hospital stay (d) 18.0 (11.0-29.0)
Death, n (%) 40 (48.2)

BMI: Body mass index; APACHEII: Acute physiology and chronic health evaluation II; SOFA: Sequential organ failure assessment; CRP: C-reactive protein; WBC: White blood cell; PCT: Procalcitonin; ARDS: Acute respiratory distress syndrome; AKI: Acute kidney injury; MODS: Multiple organ dysfunction syndrome; MV: Mechanical ventilation; CRRT: Continuous renal replacement therapy.